BioMarin (United States)
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioMarin (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
59%
Total
Publications
789
Total Open
Publications
467
Total
Citations
28K
Open Access
Percentage
59%
Total
Publications
789
Total Open
Publications
467
Total
Citations
28K
Breakdown
Publisher Open
17%
Both
33%
Other Platform Open
9%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
138
Hybrid 45%
176
No Guarantees 20%
81
Other Platform Open
Domain 81%
271
Institution 32%
105
Other Internet 11%
37
Preprint 8%
26
Public 7%
24
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 269 |
Europe PMC | Domain | 169 |
University College London - UCL Discovery | Institution | 49 |
University of California - eScholarship University of California | Institution | 19 |
Semantic Scholar | Public | 18 |
bioRxiv | Preprint | 14 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 10 |
California Digital Library - eScholarship | Other Internet | 10 |
Research Square | Preprint | 9 |
Figshare | Public | 8 |